Quarterly report [Sections 13 or 15(d)]

Equity-Based Compensation (Tables)

v3.25.1
Equity-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Schedule of Assumptions Were Utilized In Determining the Fair Value of the Units at the Grant Date The following assumptions were utilized in determining the fair value of the units at the grant date for the three months ended March 31, 2025 and 2024:
Expected dividend —
Expected volatility
60% to 85%
Risk-free interest rate
0.13% to 2.53%
Expected life of incentive awards (in years)
1 to 5 years
Grant date performance and market threshold
$35,000 to $1,250,000
The following weighted average assumptions were utilized in determining the fair value of options granted:
Three Months Ended March 31,
2025 2024
Weighted average grant date fair value $1.27 $2.18
Expected dividend — —
Expected volatility 71% 65%
Risk-free interest rate 4.05% 4.37%
Options term (in years) 4.5 4.5
The Company used the Monte Carlo pricing model to estimate the fair value of PSUs utilizing the following assumptions at the grant date for the three months ended March 31, 2025 and 2024:
Expected dividend —
Expected volatility 65%
Risk-free interest rate 3.97%
Award term years 4.3
Valuation date share price $6.21
Schedule of Changes in the Number of Incentive Units
The following table summarizes the changes in the number of Incentive Units for the three months ended March 31, 2025 and 2024:
Incentive Units Weighted Average Grant Date Fair Value
Granted and outstanding at January 1, 2025 8,472  $ 213.79 
Granted —  — 
Forfeited —  — 
Granted and outstanding at March 31, 2025
 8,472  $ 213.79 
Vested at March 31, 2025
 7,745  $ 213.64 
Granted and outstanding at January 1, 2024
 8,585  $ 213.81 
Granted —  — 
Forfeited —  — 
Granted and outstanding at March 31, 2024
 8,585  $ 213.81 
Vested at March 31, 2024
 6,507  $ 213.33 
The following table summarizes information about stock options activities for the three months ended March 31, 2025 and 2024:
Stock Options Weighted Average Exercise Price
Outstanding at January 1, 2025 5,424,411  $ 4.41 
Granted 3,752,998  2.16 
Forfeited (311,245) 3.87 
Outstanding at March 31, 2025
 8,866,164  $ 3.47 
Vested and exercisable at March 31, 2025
 752,646  $ 4.15 
Outstanding at January 1, 2024
 3,413,340  $ 5.19 
Granted 2,371,128  3.91 
Forfeited (226,832) 6.18 
Outstanding at March 31, 2024
 5,557,636  $ 4.60 
Vested and exercisable at March 31, 2024
 100,468  $ 9.51 
The following table summarizes information about the RSUs under the Omnibus Plan for the three months ended March 31, 2025 and 2024:
Restricted Stock Units Weighted Average Grant Date Fair Value
Nonvested at January 1, 2025 2,232,952  $ 4.51 
Granted 1,918,394  2.15 
Forfeited (131,652) 4.01 
Vested (319,081) 4.05 
Nonvested at March 31, 2025
 3,700,613  $ 3.35 
Nonvested at January 1, 2024
 1,684,955  $ 5.77 
Granted 1,079,772  3.91 
Forfeited (150,329) 5.63 
Vested (35,349) 6.59 
Nonvested at March 31, 2024
 2,579,049  $ 4.99